Technical Analysis for OBIO - Orchestra BioMed Holdings, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | N/A | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | 0.00% | |
| New 52 Week Closing High | Bullish | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Parabolic Rise | Strength | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| NR7 | Range Contraction | 26.42% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 20 DMA Support | 1 day ago |
| 10 DMA Support | 1 day ago |
| 60 Minute Opening Range Breakout | 1 day ago |
| Up 5% | 1 day ago |
| Up 3% | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Orchestra BioMed, Inc. operates as a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. It offers BackBeat Cardiac Neuromodulation Therapy (CNT), a patented, intelligent bioelectronic treatment for hypertension; Virtue SAB, a patented drug/device combination product for the treatment of artery disease; FreeHold Retractors, a minimally invasive surgical device solution; and Virtue SEB, a drug-eluting balloon angioplasty system for the treatment of coronary artery disease. Orchestra BioMed, Inc. has a strategic collaboration with Medtronic to develop BackBeat CNT as a potential treatment for hypertension in patients who are indicated for a cardiac pacemaker. The company was incorporated in 2017 and is based in New Hope, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Coronary Artery Disease Angioplasty Medtronic
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Coronary Artery Disease Angioplasty Medtronic
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 19.84 |
| 52 Week Low | 7.49 |
| Average Volume | 62,623 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 15.39 |
| 10-Day Moving Average | 15.80 |
| Average True Range | 2.24 |
| RSI | 68.85 |
| ADX | 32.17 |
| +DI | 32.69 |
| -DI | 11.47 |
| Chandelier Exit (Long, 3 ATRs) | 13.11 |
| Chandelier Exit (Short, 3 ATRs) | 16.44 |
| Upper Bollinger Bands | 18.84 |
| Lower Bollinger Band | 11.94 |
| Percent B (%b) | 1.11 |
| BandWidth | 44.82 |
| MACD Line | 1.44 |
| MACD Signal Line | 1.30 |
| MACD Histogram | 0.1469 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 27.67 | ||||
| Resistance 3 (R3) | 26.86 | 23.35 | 26.32 | ||
| Resistance 2 (R2) | 23.35 | 21.29 | 23.75 | 25.87 | |
| Resistance 1 (R1) | 21.46 | 20.01 | 22.40 | 22.27 | 25.42 |
| Pivot Point | 17.95 | 17.95 | 18.42 | 18.36 | 17.95 |
| Support 1 (S1) | 16.06 | 15.89 | 17.01 | 16.87 | 13.72 |
| Support 2 (S2) | 12.55 | 14.61 | 12.96 | 13.27 | |
| Support 3 (S3) | 10.66 | 12.55 | 12.82 | ||
| Support 4 (S4) | 11.47 |
